ArticleJACC. Cardiovascular interventions2022

2-Year Results With a Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions: The First-in-Human ILLUMINA Study.

Sabine Steiner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.